Today: 16 December 2025
Subscribe
Browse Category

Financial Analysis News 6 November 2025

Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Oracle (ORCL) Stock Today — November 6, 2025: Price Slides as AI-Spend Scrutiny Builds; Fresh AI Database Coverage, Gartner ‘Leader’ Nod, and New OCI Partnerships in Focus

Live ORCL snapshot (Nov 6, 2025): As of 16:38 UTC, Oracle shares trade at $241.00, down about 3.7% on the day, after ranging between $239.45–$251.41 on intraday volume of ~8.0M shares. What’s moving Oracle stock today 1) Investors wrestle with
6 November 2025
 ·  ·  ·  ·  · 
Apple’s July 2025 Bombshells: Foldable iPhone, AI Secrets, Encryption Showdown & More

Apple Stock Today (AAPL): Shares Edge Higher as Google–Gemini Siri Deal Takes Center Stage — November 6, 2025

At a glance (intraday, Nov 6, ~16:30 UTC): Apple is trading around $272 (≈+0.8% vs. Wednesday’s close), after reversing an early dip alongside broader tech weakness. Today’s range has run roughly $268–$273, with the 52‑week range at $169–$277. Reuters Why
6 November 2025
 ·  ·  ·  ·  · 
Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

What Vistra reported today Vistra posted third‑quarter 2025 GAAP net income of $652 million and Ongoing Operations Adjusted EBITDA of $1.581 billion. Management said the year‑over‑year decline in GAAP profit primarily reflects lower unrealized mark‑to‑market gains on hedging positions and
6 November 2025
 ·  ·  ·  ·  · 
Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) reported third‑quarter 2025 results this morning (Nov. 6), highlighting sequential revenue growth, materially higher gross margins, and steady commercial momentum for its tumor‑infiltrating lymphocyte (TIL) therapy Amtagvi. Management also reaffirmed full‑year revenue guidance and flagged
6 November 2025
 ·  ·  ·  ·  · 
Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

What happened in Q3 Oscar Health reported third‑quarter revenue of $2,985,984,000 (in thousands), up from $2,423,482,000 a year ago—about 23% YoY growth, driven largely by higher membership. The medical loss ratio (MLR) increased to 88.5% (from 84.6%), which the company
6 November 2025
 ·  ·  ·  ·  · 
Celsius Holdings (CELH) Q3 2025: Revenue Jumps 173% to $725.1M; GAAP Loss on Distribution Charges as PepsiCo Partnership Deepens

Celsius Holdings (CELH) Q3 2025: Revenue Jumps 173% to $725.1M; GAAP Loss on Distribution Charges as PepsiCo Partnership Deepens

At a glance (Q3 2025) Earnings headline: Big top‑line, accounting headwinds on the bottom line Celsius Holdings reported $725.1 million in Q3 sales, up 173% year over year, as the company’s broadened energy portfolio and expanded distribution powered growth. GAAP
6 November 2025
 ·  ·  ·  ·  ·  · 
Datadog (DDOG) Jumps After Q3 2025 Beat: $886M Revenue, $0.55 EPS; Full‑Year Outlook Raised

Datadog (DDOG) Jumps After Q3 2025 Beat: $886M Revenue, $0.55 EPS; Full‑Year Outlook Raised

Cloud observability and security provider Datadog (NASDAQ: DDOG) posted a stronger‑than‑expected third quarter and lifted its full‑year guidance, citing continued momentum with large customers and rapid product innovation in AI observability and security. The company reported revenue of $886 million
6 November 2025
 ·  ·  ·  ·  · 
Nasdaq Rally Amid Tech Frenzy: Markets Brush Off Shutdown Fears in Late September 2025

U.S. Stock Market Today (Nov. 6, 2025): Futures Mixed as Jobless Claims & Productivity Loom; Tesla Pay Vote, Airbnb & DraftKings Earnings in Focus

Here’s your fast, fact‑checked brief on what matters before the bell in the U.S. today (Thursday, Nov. 6, 2025). 1) Overnight & pre‑market snapshot 2) Today’s U.S. economic calendar (all times ET) Why it matters: Claims set the tone for
6 November 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
DroneShield Stock Skyrockets 40%: What’s Behind the Surge and What’s Next?

DroneShield (ASX:DRO) tumbles as 31.16m new shares hit the market after option vesting — what today’s filings mean for investors (Nov 6, 2025)

Key points What happened today (Nov 6) DroneShield shares continued to feel the aftershocks of mid‑week filings. European quotations on Tradegate showed the stock lower by about 8.3% to €2.04 at 11:30 CET on Thursday, extending Wednesday’s weakness on the
6 November 2025
 ·  ·  ·  · 
Primerica (NYSE: PRI) Q3 2025 beats: EPS $6.35; revenue $839.9M; record $3.7B ISP sales as investors eye today’s earnings call

Primerica (NYSE: PRI) Q3 2025 beats: EPS $6.35; revenue $839.9M; record $3.7B ISP sales as investors eye today’s earnings call

Published November 6, 2025 DULUTH, Ga. — Primerica (NYSE: PRI) posted stronger‑than‑expected third‑quarter 2025 results after Wednesday’s close, setting fresh records in its Investment & Savings Products (ISP) business and topping Wall Street’s earnings and revenue forecasts ahead of its
6 November 2025
 ·  ·  ·  ·  · 
1 … 78 79 80 81 82 … 103
Go toTop